Study guide

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy

Key Takeaways Explain This Topic AI

Ischaemic stroke accounts for 85% of cases; emergency non-contrast CT (NCCT) brain is essential to rule out intracranial hemorrhage before initiating reperfusion therapy.

Intravenous alteplase (0.9 mg/kg, max 90 mg) must be administered within 4.5 hours of symptom onset in eligible ischaemic stroke patients, provided BP is controlled below 185/110 mmHg.

Middle Cerebral Artery (MCA) occlusion produces contralateral hemiparesis and sensory loss affecting the face and arm more than the leg, accompanied by Broca or Wernicke aphasia in dominant hemisphere lesions.

Status epilepticus is defined as continuous seizure activity lasting ≥5 minutes; first-line therapy is IV Lorazepam (4 mg), followed by IV Fosphenytoin/Leveacetam if seizures persist.

Sodium Valproate is the drug of choice for broad-spectrum generalized seizures but is strictly contraindicated in women of childbearing potential due to high teratogenicity (neural tube defects).

Last updated: July 2026

Cerebrovascular Accidents (Stroke) & Seizure Disorders

Cerebrovascular accidents (CVA) and seizure emergencies represent core high-yield topics in UPSC CMS General Medicine. A thorough understanding of vascular anatomy, acute stroke protocols, seizure classification, and status epilepticus management is essential for clinical practice and examination success.

1. Cerebrovascular Accidents (Stroke)

Stroke is defined as an acute neurological deficit of vascular origin lasting >24 hours (or associated with acute infarction on neuroimaging). Strokes are broadly classified into Ischaemic (85%) and Haemorrhagic (15%) .

Vascular Territory Syndromes

Understanding arterial anatomy allows accurate clinical localization of ischaemic stroke:

Vascular Territory Clinical Features & Deficits Key Diagnostic Pearls

Middle Cerebral Artery (MCA) Contralateral hemiparesis & hemisensory loss ( Face + Arm > Leg ); Homonymous hemianopia; Broca's Aphasia (Superior division, dominant left MCA - expressively impaired, intact comprehension); Wernicke's Aphasia (Inferior division - fluent, impaired comprehension); Global Aphasia (stem occlusion); Hemineglect (non-dominant right MCA). Most common site of ischaemic stroke. Total anterior circulation infarct (TACI) presentation.

Anterior Cerebral Artery (ACA) Contralateral hemiparesis & hemisensory loss ( Leg > Arm + Face ); Urinary incontinence; Transcortical motor aphasia; Abulia, apathy, and frontal release signs. Recurrent artery of Heubner occlusion causes basal ganglia lacunar infarction.

Posterior Cerebral Artery (PCA) Contralateral homonymous hemianopia with macular sparing ; Alexia without agraphia (dominant PCA + splenium of corpus callosum); Dejerine-Roussy syndrome (thalamic pain); Weber syndrome (ipsilateral CN III palsy + contralateral hemiparesis). Visual cortex and thalamic involvement dominate.

Vertebrobasilar System Wallenberg Syndrome (PICA) : Ipsilateral Horner syndrome, ipsilateral facial numbness (CN V), palatal paralysis/dysphagia (CN IX, X), cerebellar ataxia + contralateral spinothalamic loss of pain/temp. Crossed deficits (ipsilateral cranial nerve + contralateral motor/sensory loss) pathognomonic for brainstem stroke.

Acute Ischaemic Stroke Management Protocol

Emergency Evaluation : Immediate NIH Stroke Scale (NIHSS) assessment, capillary blood glucose (to exclude hypoglycemia mimicking stroke), and urgent Non-Contrast Computed Tomography (NCCT) Brain .

NCCT Role : Excludes intracranial hemorrhage (hypodense ischaemic changes may be subtle within the first 6 hours; early signs include hyperdense MCA sign, loss of insular ribbon, and sulcal effacement).

Intravenous Thrombolysis :

Drug & Dose : Recombinant tissue plasminogen activator ( Alteplase / rtPA ) at 0.9 mg/kg (maximum 90 mg; 10% given as IV bolus over 1 minute, remainder infused over 60 minutes).

Time Window : Within 4.5 hours of symptom onset (or well time).

Blood Pressure Ceiling : BP must be <185/110 mmHg before starting alteplase and maintained <180/105 mmHg for 24 hours post-thrombolysis.

Absolute Contraindications : Active internal bleeding, intracranial hemorrhage history, head trauma/stroke within 3 months, arterial puncture at non-compressible site within 7 days, INR >1.7 or platelets <100,000/mm³, blood pressure >185/110 mmHg resistant to acute antihypertensive therapy.

Mechanical Thrombectomy : Indicated for Large Vessel Occlusion (LVO - ICA or proximal MCA M1 segment) within 6 to 24 hours of onset using stent retrievers/aspiration catheters.

Secondary Prevention : Aspirin 150-300 mg daily started 24 hours post-thrombolysis (or immediately if non-thrombolysed), High-intensity statin (Atorvastatin 80 mg daily), Blood pressure optimization, and oral anticoagulation (Apixaban/Dabigatran/Warfarin) for atrial fibrillation after 3-14 days depending on infarct size.

Subarachnoid Hemorrhage (SAH)

Etiology : Rupture of saccular (berry) aneurysms (85%), most commonly located at the Anterior Communicating Artery (ACom) junction.

Clinical Presentation : Sudden onset "thunderclap" headache ("worst headache of life"), vomiting, transient loss of consciousness, neck stiffness (nuchal rigidity), Kernig and Brudzinski signs.

Diagnosis : Non-contrast CT brain (>95% sensitive in first 6 hours). If CT is negative but clinical suspicion remains high, lumbar puncture is mandatory to evaluate for xanthochromia (yellow CSF supernatant from hemoglobin breakdown, developing 6-12 hours post-event).

Complication & Prevention : Cerebral vasospasm occurs between days 4-14 post-SAH. Enteral Nimodipine 60 mg every 4 hours for 21 days significantly reduces ischaemic deficits from vasospasm.

Loading diagram... Acute Ischaemic Stroke Emergency Management Pathway

2. Epilepsy & Status Epilepticus

Epilepsy is defined as at least two unprovoked seizures occurring >24 hours apart, or one unprovoked seizure with a high risk (>60%) of recurrence over the next 10 years.

ILAE Seizure Classification & Clinical Syndromes

Focal Seizures : Originate within networks limited to one cerebral hemisphere.

Focal Aware : Consciousness preserved.

Focal Impaired Awareness : Consciousness altered or lost; frequently accompanied by automatisms (lip-smacking, swallowing, hand-rubbing). Temporal lobe origin most common (associated with hippocampal sclerosis).

Generalized Seizures : Originate at some point within and rapidly engage bilaterally distributed networks.

Absence Seizures (Petit Mal) : Brief (5-10 sec) sudden impairment of consciousness with sudden onset/offset, no post-ictal state. EEG shows classic 3 Hz generalized spike-and-wave pattern . First-line treatment: Ethosuximide or Sodium Valproate .

Juvenile Myoclonic Epilepsy (JME) : Onset in adolescence; characterized by morning myoclonic jerks (dropping coffee cup), generalized tonic-clonic seizures (GTCS), and absence seizures. EEG shows 4-6 Hz polyspike-wave pattern . First-line treatment: Sodium Valproate or Levetiracetam . Note : Carbamazepine and Phenytoin can aggravate myoclonus!

Status Epilepticus Management Protocol

Status epilepticus is defined as continuous seizure activity lasting ≥5 minutes (t1) or ≥2 recurrent seizures without recovery of consciousness between episodes. Neuronal damage becomes irreversible after 30 minutes (t2). [0 - 5 min]: INITIAL EVALUATION & ABCs

  • ├─ Airway maintenance, 100% Oxygen, IV access, Capillary Blood Glucose
  • └─ If Hypoglycaemic: Give 50 mL 50% Dextrose + 100 mg Thiamine IV
  • [5 - 20 min]: FIRST-LINE THERAPY (Emergent / Benzodiazepines)
  • ├─ IV Lorazepam 4 mg (0.1 mg/kg) over 2 min [DRUG OF CHOICE]
  • ├─ OR IV Diazepam 10 mg (0.2 mg/kg) over 2 min
  • └─ OR IM Midazolam 10 mg (if IV access unavailable)
  • [20 - 40 min]: SECOND-LINE THERAPY (Urgent Control / Non-sedating AEDs)
  • ├─ IV Fosphenytoin 20 mg PE/kg (max 150 mg PE/min; monitor ECG & BP)
  • ├─ OR IV Levetiracetam 60 mg/kg (max 4500 mg)
  • └─ OR IV Sodium Valproate 40 mg/kg (max 3000 mg)

[> 40 min]: THIRD-LINE THERAPY (Refractory Status Epilepticus)

└─ General Anaesthesia + Intubation with continuous EEG monitoring:

  • IV Propofol OR IV Midazolam infusion OR IV Thiopental
  • Comprehensive Anti-Epileptic Drug (AED) Summary Table

Drug Primary Mechanism of Action Key Clinical Indications High-Yield Side Effects & Exam Pearls

Phenytoin Na+ channel blocker (use-dependent) Focal seizures, GTCS, 2nd-line status epilepticus Zero-order kinetics at therapeutic levels. Side effects: Gingival hyperplasia, hirsutism, nystagmus, ataxia, osteomalacia, megaloblastic anemia (folate deficiency), Fetal Hydantoin Syndrome (cleft lip/palate, cardiac defects).

Carbamazepine Na+ channel blocker Focal seizures (Drug of Choice), Trigeminal Neuralgia Auto-induction of CYP3A4 enzymes. Side effects: Hyponatremia (SIADH-like effect), aplastic anemia, agranulocytosis, Stevens-Johnson syndrome (screen for HLA-B*1502 in Asian populations).

Sodium Valproate Broad spectrum: Na+ block, GABA enhancement, T-type Ca2+ block Broad-spectrum: GTCS, Focal, Absence, Myoclonic (JME) Teratogenic : Spina bifida/neural tube defects (avoid in pregnancy). Side effects: Weight gain, alopecia, hepatotoxicity, acute pancreatitis, hyperammonemia.

Ethosuximide T-type Ca2+ channel blocker in thalamic neurons Absence Seizures (First-line choice in children) Highly selective for absence seizures. Has no efficacy in GTCS or focal seizures. Side effects: Gastric distress, lethargy.

Levetiracetam Binds SV2A synaptic vesicle protein Focal, GTCS, Myoclonic seizures Minimal drug interactions, excreted renally. Key side effect: Behavioral changes (irritability, agitation, depression).

Lamotrigine Na+ block, inhibits glutamate release Focal, GTCS, Absence, Bipolar depression High risk of severe cutaneous adverse reactions ( Stevens-Johnson Syndrome / TEN ); dosage must be titrated very slowly. Valproate doubles lamotrigine half-life!